Orange Book product · Generic (ANDA)
HALOPERIDOL
HALOPERIDOL LACTATE
At a glance
Sep 28, 1993
Approved
Generic (ANDA)
Application
AA
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 28, 1993
33 yr 2 mo ago
Today
Pharmaceutical detail
Active ingredient
HALOPERIDOL LACTATE
Strength
EQ 2MG BASE/ML
Dosage form
CONCENTRATE
Route
ORAL
TE code
AA
Application
ANDA 073364
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of HALOPERIDOL LACTATE
- —HALDOLBrand (NDA)
NDA 015922 · ORTHO MCNEIL
- —HALDOLBrand (NDA)
NDA 015923 · JANSSEN PHARMS
- 2024HALOPERIDOLGeneric (ANDA)
ANDA 218371 · RUBICON RESEARCH
- 2019HALOPERIDOLGeneric (ANDA)
ANDA 210356 · FRESENIUS KABI USA
- 2017HALOPERIDOLGeneric (ANDA)
ANDA 204849 · EPIC PHARMA LLC
- 2011HALOPERIDOLGeneric (ANDA)
ANDA 091637 · SAGENT PHARMS
- 2011HALOPERIDOLGeneric (ANDA)
ANDA 200742 · SAGENT PHARMS
- 2009HALOPERIDOLGeneric (ANDA)
ANDA 078347 · MYLAN LABS LTD
- 2004HALOPERIDOLGeneric (ANDA)
ANDA 076464 · FOSUN PHARMA
- 2004HALOPERIDOLGeneric (ANDA)
ANDA 076791 · BAXTER HLTHCARE CORP
- 2004HALOPERIDOLGeneric (ANDA)
ANDA 076828 · BAXTER HLTHCARE CORP
- 2004HALOPERIDOLGeneric (ANDA)
ANDA 076774 · GLAND PHARMA LTD
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
